ePrescribing Masterclass

10/11/2021 1:00 pm to 10/11/2021 2:00 pm

Event Details

The ePrescribing masterclass series consists of a monthly webinar where NHS organisations can share their learning and experiences on digital transformation and enabling Trusts to follow in their footsteps as quickly and effectively as possible.

The sessions are designed to accelerate digital transformation, reduce unwarranted variation, and deliver quality improvements in patient safety, clinical outcomes, and service user experience. It is also an opportunity for people to present at a national level.

The events will be of interest to Pharmacy teams, Implementation teams, IT teams, CCIOs, CMIOs and suppliers.

The series was set up by Ann Slee, NHS England’s Associate Chief Clinical Information Officer (Medicines). Ann is a hospital pharmacist by background and has led various local and national initiatives around digital medicines and ePrescribing with experience in the development and deployment of digital technologies. She holds several honorary academic appointments and was a member of the advisory board for the Wachter review.

Ann is a Founding Fellow of the Faculty of Clinical Informatics.

A certificate of attendance is available if viewing on GoTo.

Upcoming ePrescribing Masterclass Dates


Wednesday 10th November 1-2pm

Register for 10 November masterclass


Wednesday 15th December 1-2pm.


Each masterclass will last approximately 60 minutes. Sessions will be delivered via GoToWebinar.

Recordings of all sessions will be available.

Previous Events

October  Masterclass

Watch the October Recording

September Masterclass

Watch the September Recording

July Masterclass

Watch the July Recording

June Masterclass

Watch the June Recording

May Masterclass

Watch the May Recording 

April Masterclass

Watch the April Recording

Download the Event Q and A


Watch the March Recording


Watch the February Recording 


For further information please contact [email protected]


By utilising dm+d organisations are able to unlock the benefits of interoperability between clinical systems. This includes the elimination of transcriptions of medications from ePMA/EPR to electronic discharge summaries and improved medicines ordering through electronic ordering and integration with the pharmacy stock control system.

In addition to interoperability benefits, utilising dm+d natively for ePMA/EPR systems allows for structured application of the UK default rules for medicines structure without having to configure it and allows for application of specific configurations to be applied to different levels of prescribing and allows for the customisation of drug files without changing the underlying data structure.